| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.209 | 37.516 | 58.872 | 76.872 | 92.109 |
| Total Income - EUR | - | - | - | - | - | 11.209 | 37.516 | 58.872 | 76.872 | 102.115 |
| Total Expenses - EUR | - | - | - | - | - | 3.042 | 13.713 | 28.093 | 41.950 | 62.347 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.166 | 23.803 | 30.779 | 34.922 | 39.768 |
| Net Profit/Loss - EUR | - | - | - | - | - | 7.830 | 22.678 | 29.364 | 34.169 | 37.072 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endocabinet Dr. Şcheau-Fodor Mihaela S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 20.262 |
| Current Assets | - | - | - | - | - | 6.143 | 25.659 | 54.833 | 42.761 | 42.893 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 117 | 0 |
| Receivables | - | - | - | - | - | 1.323 | 6.442 | 12.651 | 30.765 | 30.089 |
| Cash | - | - | - | - | - | 4.820 | 19.217 | 42.182 | 11.880 | 12.804 |
| Shareholders Funds | - | - | - | - | - | 7.871 | 27.343 | 56.791 | 39.787 | 37.112 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 336 | 336 | 68 | 4.994 | 26.042 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endocabinet Dr. Şcheau-Fodor Mihaela S.r.l.